Yew Bio-Pharm Group, Inc.

Q: Sep 30 2021

Q: Jun 30 2021

Q: Mar 31 2021

FY: Dec 31 2020

Q: Sep 30 2020

Q: Jun 30 2020

Q: Mar 31 2020

FY: Dec 31 2019

Q: Sep 30 2019

Q: Jun 30 2019

Q: Mar 31 2019

Q: Mar 31 2019

FY: Dec 31 2018

FY: Dec 31 2018

Q: Sep 30 2018

Q: Sep 30 2018

Q: Jun 30 2018

Q: Mar 31 2018

FY: Dec 31 2017

Q: Sep 30 2017

5.02

5.02

5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

8.01

5.02

8.01

5.02

4.01,9.01

5.02

7.01,9.01

7.01,9.01

5.02

2.02,9.01

7.01,9.01

2.02,9.01

2.03

1.01,2.03,9.01

1.01,2.03,7.01,9.01

1.01,7.01,9.01

Notice of Effectiveness

Amended Initial Registration Statement

Registration (IPO) statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Amended Initial Registration Statement

Amended Initial Registration Statement

Registration (IPO) statement under Securities Act of 1933

No description available

No description available

No description available

No description available

No description available

No description available

No description available

No description available

No description available

No description available

No description available

No description available

No description available

No description available

No description available

No description available

No description available

No description available

Definitive Proxy Statement

Definitive Proxy Statement

No description available

Preliminary Proxy Statement

Wu Xuehai

Tian Guoshuang

Liu Xiefeng

Shi Yongchun

Han Xingming

Qi Guifang

Qi Guifang

Qi Guifang

Wang Zhiguo

Han Xingming

Wang Zhiguo

Qi Guifang

Wang Zhiguo

Qi Guifang

WASSERMAN ADAM C

Han Xingming

No description available

Definitive information statement

Definitive information statement

Definitive information statement

Definitive information statement

Definitive information statement

Definitive information statement

Definitive information statement

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Annual Report Scanned (Paper)

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC